Our research effectively demonstrates the positive association between USP30-AS1 expression levels and several types of immune cells, like Th1 cells, suggesting a vital role of this gene in shaping the immune landscape in ovarian carcinoma. The gene discussed is USP30; the disease is ovarian carcinoma.